09.04.2018 • NewsDede WillamsIneosVAM

Ineos Says Europe VAM Plans Progressing

Ineos European VAM Plans Progressing © Ineos
Ineos European VAM Plans Progressing © Ineos

Ineos said last week it is making progress on its plans announced in September 2017 to build a 300,000 t/y plant for vinyl acetate monomer (VAM) at one of its integrated European production sites to reduce dependence on imports.

In its first communication about the facility in more than six months, the Swiss-headquartered petrochemicals group said it has signed a Memorandum of Understanding with an unnamed commercial partner and has begun front-end engineering and design (FEED) studies for the project.

Ineos said it expects to make a final decision on the investment over the course of 2018,  together with its designated partner, which some observers speculate could be an inporter or distributor. A start-up date of 2021 is tentatively being targeted.

Although the group has not revealed its preferred location for the VAM plant, it said the choice is now down to Antwerp, Belgium, or Hull, England. Both sides are back-integrated into ethylene, and Ineos Oxide CEO Graham Beesley said both are well positioned to supply European as well as deep-sea VAM markets. A site at Cologne, Germany, originally had been under consideration.

Due to the group’s protracted silence on the as yet unquantified investment, some European market watchers speculated that Ineos might have abandoned the VAM plans.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.